Lifeward Ltd. (NASDAQ:LFWD) Short Interest Up 18.8% in February

Lifeward Ltd. (NASDAQ:LFWD) saw a large growth in short interest in February. As of February 13th, there was short interest totaling 2,351,929 shares, a growth of 18.8% from the January 29th total of 1,979,952 shares. Approximately 13.1% of the company’s stock are short sold. Based on an average trading volume of 241,976 shares, the days-to-cover ratio is currently 9.7 days. Based on an average trading volume of 241,976 shares, the days-to-cover ratio is currently 9.7 days. Approximately 13.1% of the company’s stock are short sold.

Institutional Investors Weigh In On Lifeward

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. HRT Financial LP increased its stake in shares of Lifeward by 149.7% in the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after purchasing an additional 29,423 shares during the last quarter. Jane Street Group LLC grew its holdings in shares of Lifeward by 77.3% during the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after purchasing an additional 29,927 shares during the last quarter. Virtu Financial LLC raised its holdings in Lifeward by 158.0% in the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after buying an additional 37,037 shares during the last quarter. Finally, Citadel Advisors LLC raised its stake in shares of Lifeward by 1,271.8% during the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after acquiring an additional 198,406 shares during the last quarter. 26.76% of the stock is currently owned by institutional investors.

Lifeward Trading Down 6.4%

NASDAQ:LFWD traded down $0.41 during trading hours on Wednesday, reaching $5.99. 20,485 shares of the company were exchanged, compared to its average volume of 28,396. The business has a 50 day moving average of $7.08 and a 200 day moving average of $7.47. Lifeward has a 1-year low of $4.14 and a 1-year high of $35.40.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on LFWD shares. HC Wainwright cut their price target on shares of Lifeward from $156.00 to $54.00 and set a “buy” rating on the stock in a research report on Tuesday, November 18th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Lifeward in a research note on Thursday, January 22nd. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $51.00.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.